Journals in Clinical pharmacology therapeutics

1-10 of 14 results in All results

ASPET Discovery

• ISSN: 3050-5674

This open access journal publishes a range of article types, including original research articles, minireviews, and viewpoints that address all areas of pharmacology and experimental therapeutics. These areas include, but are not limited to, topics on interactions of chemicals with biological systems; drug absorption, distribution, metabolism and disposition; drug delivery; mechanisms of drug actions; pharmacokinetics and pharmacodynamics; toxicology and adverse drug responses; behavioral pharmacology and drugs of abuse; and preclinical, translational, and clinical pharmacology. The journal will cover all types of therapeutic indications, such as cardiovascular, infectious, neurological, and cancerous; all forms of therapeutics, such as small molecules, biologics, and cells; and all research approaches, such as molecular, cellular, and systems pharmacology.

Subscribe

Biomedicine & Pharmacotherapy

• ISSN: 0753-3322
• 5 Year impact factor: 6.8
• Impact factor: 6.9

Biomedicine & Pharmacotherapy is a multidisciplinary journal which publishes full-length, original research reports, reviews, and preliminary communications or letters to the editor which fall within the general scope of clinical and basic medicine and pharmacology.The general fields of interest will include Cancer, Nutriceutics, Neurodegenerative, Cardiac and Infectious Diseases.Special emphasis will be placed on studies of specific topics such as molecular mechanisms, gene regulation in normal and pathologic cells as well as susceptibility in response to oncogenic agents. Effects of drugs on preclinical and clinical pharmacology and the role of bacteria, viruses and parasites in animals and humans.Brief reports of meetings, symposia and conferences will also be considered for publication as well as brief listings of scientific meetings or academic courses of interest to the readers

Subscribe

Clinical Microbiology Newsletter

• ISSN: 0196-4399

Clinical Microbiology Newsletter is published bi-monthly to to provide consistent educational features and to keep pace with advances in the fast-moving field of Clinical Microbiology.Clinical Microbiology Newsletter aims to provide articles to enable you to streamline procedures and improve results. It publishes reviews on infectious disease pathogens, reports on changes that affect your work, including articles on new diagnostic techniques, regulatory and guideline changes, and challenging diagnostic dogmas, clinical cases focused on diagnostic approaches for both common and uncommon pathogens.The journal publishes three types of articles:Mini-reviews Case presentationsMicrobe SnapshotsThese articles cover topics including:Minireviews on the epidemiology, pathogenesis, clinical presentation, diagnosis, and treatment of infectious diseases,Practical articles on common and contemporary laboratory techniques,Indispensable updates on important clinical problems that impact the clinical laboratory,Editorials and opinions on controversial issues in laboratory medicine,Case-based articles focused on diagnostic approaches for infectious pathogens,Snapshots highlighting specific infectious pathogens,Helpful tips on improving the laboratory workplace.

Subscribe

Clinical Therapeutics

• ISSN: 0149-2918
• 5 Year impact factor: 3
• Impact factor: 3.2

The International Peer-Reviewed Journal of Drug TherapyClinical Therapeutics provides peer-reviewed, rapid publication of recent developments in drug and other therapies as well as in diagnostics, pharmacoeconomics, health policy, treatment outcomes, and innovations in drug and biologics research. In addition Clinical Therapeutics features updates on specific topics collated by expert Topic Editors. Clinical Therapeutics is read by a large international audience of scientists and clinicians in a variety of research, academic, and clinical practice settings. Articles are indexed by all major biomedical abstracting databases.Published articles range from pivotal studies exploring new chemical entities in large, multicenter trials to those exploring repurposing of marketed agents. Additionally, pilot studies; reports that assess drug safety and tolera-bility in all phases of development; new routes of administration and new formulations; pharmacokinetic, bio-availability, and biosimilarity; and changes in practice guidelines and standards, are all of interest for publication. Clinical Therapeutics also understands the importance of strengthening the body of evidence surrounding particular agents through the publication of replication studies, negative trials, and failed trials.Beyond the clinic, we seek reports that examine the real-world implications of therapeutics such as comparative effectiveness and pharmacoeconomics studies as well as work that has implications for health policy. Commentaries, which include perspectives and contemporary issues, are sought to offer a balance of viewpoints and scholarly opinion on a broad array of drug-related topics. Case reports, which remain a vital part of our mission, offer clinically valuable lessons. All manuscripts are peer reviewed by independent clinicians or scientists for clinical relevance, technical accuracy, methodological rigor, clarity, and objectivity using a blind review process.In addition to feature articles published monthly, each issue of Clinical Therapeutics features a specific theme section dedicated to an annual update of a specific topic area. A special guest editor will comprise each update with reviews, commentaries, and original research highlighting what's new or controversial in the topical specialty. Authors are invited to submit manuscripts for consideration in the topic updates, identifying submissions as such in their cover letters. Submissions not selected for the updates will be considered for general publication. Submit your manuscript at https://www.editorialmanager.com/clinther.

Subscribe

Contraception

• ISSN: 0010-7824
• 5 Year impact factor: 2.7
• Impact factor: 2.8

An international reproductive health journal The Official Journal of the Society of Family PlanningThe journal Contraception wishes to advance reproductive health through the rapid publication of the best and most interesting new scholarship regarding contraception and related fields such as abortion. The journal welcomes manuscripts from investigators working in the laboratory, clinical and social sciences, as well as public health and health professions education.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center.

Subscribe

Current Therapeutic Research

• ISSN: 0011-393X
• 5 Year impact factor: 1.8
• Impact factor: 1.6

Current Therapeutic Research (CTR) is a multidisciplinary, peer-reviewed Open Access journal focusing on the discovery, development, and use of therapeutics and interventions across all therapeutic areas and all aspects of therapy. It is read by a large international audience of scientists and healthcare professionals in various research, academic, and clinical practice settings. Articles published in CTR are indexed by all major biomedical abstracting databases (e.g., PubMed/Medline, Clarivate, Scopus).CTR aims to publish high-quality, rigorous, and ethically sound original research, be it positive, confirmatory, or negative data, with the goal of improving healthcare. The journal welcomes in-depth review articles, meta-analyses, commentaries, brief reports, case reports, research letters, and letters to the editor.CTR promotes collaborative and interdisciplinary work with objectivity, criticism, creativity, innovation, and respect for cultural and professional diversity. By doing so, the journal provides a communication space for all therapists, regardless of their discipline or specialty.CTR areas of interest:Experimental medicine and therapeutics, translational medicine, clinical use of medicines and safe medication prescribing.Topics related to new or existing drug pharmacology, such as pharmacotherapy, pharmacovigilance, pharmacoeconomics, pharmacoepidemiology, personalized medicine and ethnopharmacology.Pharmaceutical topics including clinical trials, medicinal chemistry, drug disposition and effects, pharmaceutical medicine, pharmacodynamics, pharmacokinetics and toxicology.Pharmacometrics: PK/PD modeling, PBPK modeling, clinical trial modeling and simulation.Complementary medicine and therapies topics, including natural or herbal medicines that complement or replace conventional therapies - biological mechanisms of action, efficacy, safety, costs, patterns of use and implementation.Studies relating to stem-cell and nutritional therapy, diagnostics and diagnosis, public health, quality of life, patient care, management, and education are also encouraged.Interventions focused on all aspects of clinical therapy, including non-pharmacological ones.Emphasis will be placed on studies of specific topics such as pediatric clinical trials and pediatric and maternal-fetal pharmacology and toxicology.Research may involve preclinical and clinical studies and utilize both in vitro and in vivo approaches.Please note that the journal does not publish research on traditional medicines (e.g., traditional Chinese medicine, Kampo medicine, a Japanese traditional medicine) or studies involving crude natural products.Finally, CTR promotes inclusion and diversity by considering submissions from all over the world, whether they relate to an international or a country-specific audience (e.g., a specific patient population).Submit your manuscript at https://www.editorialmanager.com/curtherres.

Subscribe

Drug Metabolism and Disposition

• ISSN: 0090-9556

An important reference for all pharmacology and toxicology departments, DMD is also a valuable resource for medicinal chemists involved in drug design and biochemists with an interest in drug metabolism, expression of drug metabolizing enzymes, and regulation of drug metabolism enzyme gene expression. Articles provide experimental results from in vitro and in vivo systems that bring you significant and original information on metabolism and disposition of endogenous and exogenous compounds, including pharmacologic agents and environmental chemicals.

Subscribe

European Journal of Cancer

• ISSN: 0959-8049
• 5 Year impact factor: 7.7
• Impact factor: 7.6

Official Journal of EORTC and EUSOMAThe European Journal of Cancer (EJC) integrates preclinical, digital, translational, and clinical research in cancer, from epidemiology, carcinogenesis and biology through to innovations in cancer treatment and patient care. The journal publishes original research, reviews, previews, editorial comments and correspondence.The EJC is the official journal of the European Organisation for Research and Treatment of Cancer (EORTC) and the European Society of Breast Cancer Specialists (EUSOMA).

Subscribe

European Journal of Cancer: Supplement

• ISSN: 1359-6349

EJC Supplements is an open access companion journal to the European Journal of Cancer. As an open access journal, all published articles are subject to an Article Publication Fee. Immediately upon publication, all articles in EJC Supplements are made openly available through the journal's websites.EJC Supplements will consider for publication the proceedings of scientific symposia, commissioned thematic issues, and collections of invited articles on preclinical and basic cancer research, translational oncology, clinical oncology and cancer epidemiology and prevention.Authors considering the publication of a supplement in EJC Supplements are requested to contact the Editorial Office of the EJC to discuss their proposal with the Editor-in-Chief.EJC Supplements is an official journal of the European Organisation for Research and Treatment of Cancer (EORTC), the European CanCer Organisation (ECCO) and the European Society of Mastology (EUSOMA).

Subscribe

Heliyon

• ISSN: 2405-8440
• 5 Year impact factor: 3.9
• Impact factor: 3.4

Heliyon considers research from all areas of the physical, applied, life, social and medical sciences. We publish manuscripts reporting scientifically accurate and valuable research, which adheres to accepted ethical and scientific publishing standards. As such Heliyon publishes new insights as well as extensions on existing theories, negative/null results and replication studies.Submissions covering arts, humanities and law are not considered in Heliyon. Authors of these submissions are encouraged to submit directly to our partner journal Social Sciences & Humanities Open.Heliyon classifies manuscripts/articles into different sections based on the research topic discussed. Some sections exclude certain types of studies from their scope. To know more and to see the kind of manuscripts the various sections publish, please visit: https://www.cell.com/heliyon/sectionsA dedicated in-house editorial office team, internal editors as well as external academic section and associate editors handle your manuscript and manage the publication process, giving your research the editorial support and quality control it deserves.If it's important to you, it's important to us. Submit your paper today.

Subscribe